Cargando…

Estimating impact of food choices on life expectancy: A modeling study

BACKGROUND: Interpreting and utilizing the findings of nutritional research can be challenging to clinicians, policy makers, and even researchers. To make better decisions about diet, innovative methods that integrate best evidence are needed. We have developed a decision support model that predicts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fadnes, Lars T., Økland, Jan-Magnus, Haaland, Øystein A., Johansson, Kjell Arne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824353/ https://www.ncbi.nlm.nih.gov/pubmed/35134067 http://dx.doi.org/10.1371/journal.pmed.1003889

Ejemplares similares

Correction: Estimating impact of food choices on life expectancy: A modeling study
por: Fadnes, Lars T., et al.
Publicado: (2022)

Life expectancy can increase by up to 10 years following sustained shifts towards healthier diets in the United Kingdom
por: Fadnes, Lars T., et al.
Publicado: (2023)

Estimating Health Adjusted Age at Death (HAAD)
por: Johansson, Kjell Arne, et al.
Publicado: (2020)

Age, Risk, and Life Expectancy in Norwegian Intensive Care: A Registry-Based Population Modelling Study
por: Lindemark, Frode, et al.
Publicado: (2015)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

A flexible formula for incorporating distributive concerns into cost-effectiveness analyses: Priority weights
por: Haaland, Øystein Ariansen, et al.
Publicado: (2019)

Prioritizing Child Health Interventions in Ethiopia: Modeling Impact on Child Mortality, Life Expectancy and Inequality in Age at Death
por: Onarheim, Kristine Husøy, et al.
Publicado: (2012)

Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis
por: Lindemark, Frode, et al.
Publicado: (2017)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Financial hardship associated with catastrophic out-of-pocket spending tied to primary care services in low- and lower-middle-income countries: findings from a modeling study
por: Bolongaita, Sarah, et al.
Publicado: (2023)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

UPDATING ESTIMATES OF DRIVING LIFE EXPECTANCY
por: Vivoda, Jonathon
Publicado: (2022)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Treatment of Severe Aortic Valve Stenosis: Impact of Patient Sex and Life Expectancy on Treatment Choice
por: Rashedi, Nina, et al.
Publicado: (2022)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

Health equity impact of community-initiated kangaroo mother care: a randomized controlled trial
por: Choudhary, Tarun Shankar, et al.
Publicado: (2021)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

An Alternative Mathematical Modeling Approach to Estimating a Reference Life Expectancy
por: Stevens, Elizabeth R., et al.
Publicado: (2019)

The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells
por: Fadnes, Bodil, et al.
Publicado: (2009)

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021)

Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada
por: Loukine, Lidia, et al.
Publicado: (2012)

Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer
por: Andersson, Therese M.-L., et al.
Publicado: (2019)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Positioning of aquatic animals based on time-of-arrival and random walk models using YAPS (Yet Another Positioning Solver)
por: Baktoft, Henrik, et al.
Publicado: (2017)

Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
por: Fadnes, Bodil, et al.
Publicado: (2011)

Uncertainties Associated with Quantifying Climate Change Impacts on Human Health: A Case Study for Diarrhea
por: Kolstad, Erik W., et al.
Publicado: (2011)

Estimating the long term impact of kidney donation on life expectancy and end stage renal disease
por: Kiberd, Bryce A
Publicado: (2013)

Life Expectancy Predictions for Older Diabetic Patients as Estimated by Physicians and a Prognostic Model
por: O’Hanlon, Claire E., et al.
Publicado: (2017)

Estimating the Effects of [Formula: see text] on Life Expectancy Using Causal Modeling Methods
por: Schwartz, Joel D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ol26omrgqksg0d71e0bohr9mp